LONDON (Reuters) - AstraZeneca, determined to show it has a strong independent future after seeing off a $118 billion bid from Pfizer in May, said it had made good progress in developing a pipeline of new drugs. The company flagged its "industry-leading" portfolio of immune-boosting cancer drugs and said that across all disease areas it had the potential to secure between eight and 10 approvals for new medicines in 2015-2016. AstraZeneca executives will present further details at a six-hour investor meeting later on Tuesday. ...
via Health News Headlines - Yahoo News Read More Here..
No comments:
Post a Comment